Massachusetts General Hospital Cancer Center — Biomedical Watch V2

Essais liés8clinical trials

VilleBostonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03984448

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Biospecimen Collection	Cancer	Phase 2	NCT06770582	Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT07097142	Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study	RECRUITING
Atezolizumab	Cancer	Phase 2	NCT03141684	Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma	ACTIVE_NOT_RECRUITING
Arm A: Gedatolisib + Palbociclib + Fulvestrant	Cancer	Phase 3	NCT06757634	Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)	RECRUITING
Biospecimen Collection	SEP	Phase 2/3	NCT03984448	Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas	ACTIVE_NOT_RECRUITING
Bone Scan	Cancer	Phase 2/3	NCT05691478	A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	SUSPENDED
Biospecimen Collection	Lupus	Phase 1	NCT03816345	Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	RECRUITING
Bevacizumab	Cancer	Phase 2	NCT00861705	Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	COMPLETED